HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay], Molecular Assays [PCR based molecular assays, Sequencing based molecular assays {Sanger Sequencing, Next Generation Sequencing}

HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay], Molecular Assays [PCR based molecular assays, Sequencing based molecular assays {Sanger Sequencing, Next Generation Sequencing}]), By Product and Services (Instruments, Reagents and Consumables, Software, Services), By Application (Diagnostics, Research), By End-Use (Hospitals, Academic and Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

HLA Typing for Transplant Market will exceed USD 0.8 billion by 2025; as per a new research report.

Increasing number of soft tissue, stem cells, and solid organ transplantations coupled with technological advancements in HLA typing are the foremost driving factors for HLA typing for transplant business growth over the forecast timeframe. In addition, increasing number of solid organ transplants, technological advancements and growing geriatric population will boost the global HLA typing for transplant market growth. Asia Pacific will experience lucrative growth opportunities in the coming years mainly due to high presence of unmet organ needs with infrastructural development and burgeoning disposable income in the developing economies of the region.

There has been a paradigm shift in the solid organ transplantation technique from experimental procedure to necessary and lifesaving surgery. According to the U.S department of Health and Human Services, 92 transplants occur in U.S. each day. Similarly, 31,839 organ transplants have been performed in U.S. from January- November 2017. As HLA testing techniques are used to match organ transplant recipients with compatible donors, the increase in transplants would eventually fuel the growth of market.

Molecular assays market held the majority of market share in the year 2018 and was valued at USD 319.7 million. Growth in the molecular assay segment is attributed to rising end-user preference for affordable and efficient DNA sequencing technologies, the continuously increasing demand for high-throughput DNA sequencers in HLA typing, expansion in application horizons of NGS in tissue typing, and increasing usage of NGS systems among researchers and diagnostic laboratories.

Reagents and consumables market is estimated to witness a considerable amount of growth at a CAGR of 11.4% during the projection period. High demand for reagents and consumables accompanied by significant price and high margin in kits are one of the reason for elevated market share of the segment. Volume sales also has a positive effect on the revenue generated by reagents and consumables segment, thereby enhancing the segment growth.

Diagnostics market held the major market share and was valued at around USD 308.3 million in the year 2018. Increasing incidence and prevalence of chronic diseases leading to need for organ transplant will boost the market for diagnostics application. Kidney transplant is the most common organ transplant done globally. Increasing awareness activities for organ donations by public, private institutions and NGOs is likely to improve current demand for HLA typing diagnostic application.

The hospitals segment is projected to grow at a robust CAGR of 11.2% over the forecast timeframe. Hospitals are responsible to conduct most of the diagnostics tests required HLA typing for organ transplant and thus accounted for maximum market share in 2018. Furthermore, rising number of patient visit and growing number of transplant procedures that occurs mostly in hospitals will increase demand for HLA typing in the coming year.

U.S. dominated the North America HLA typing for transplant market and was valued at around USD 133.5 million in the year 2018. Growth in U.S. is primarily supported by the strongly increasing number of organ transplantations. The country has witnessed around 20 percent of increase in number of organ transplantations from 2012 to end of the 2017 which accounts for 33,600 transplantations in the year 2016. Asia Pacific will grow at significant rate as a result of growing hematopoietic transplantation, increasing number of bone marrow donors. Additionally, rising awareness about cord banking and organ transplantation will boost Asia Pacific business growth.

The major industry players in the HLA typing for transplant market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc. and Bio-Rad Laboratories. These companies mainly focus on the strategies such as merger, acquisition, new product development and new product launches in order to enhance their product portfolio and strengthen the market position.